 <h1>Norcuron Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>vecuronium</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about vecuronium. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Norcuron.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to vecuronium: parenteral powder for injection</i></p><h3>Warning</h3><p><ul>
<li>
Should be administered only by adequately trained clinicians experienced in the use and complications of neuromuscular blocking agents.&lt;sup&gt;1&lt;/sup&gt;</li></ul></p><ul>
<li>
Should be administered only by adequately trained clinicians experienced in the use and complications of neuromuscular blocking agents.&lt;sup&gt;1&lt;/sup&gt;</li></ul><p></p><p>Side effects include:</p><p>Skeletal muscle weakness. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to vecuronium: intravenous powder for injection, intravenous solution</i></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity, anaphylactic reaction, anaphylactoid reaction, anaphylactic shock, anaphylactoid shock<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (0.01% to 0.1%): Prolonged neuromuscular block </p><p><b>Very rare</b> (less than 0.01%): Flaccid paralysis, muscular weakness, steroid myopathy<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very rare</b> (less than 0.01%): Bronchospasm, airway complication of anesthesia<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very rare</b> (less than 0.01%): Injection site pain, injection site reaction<sup>[Ref]</sup></p><h3>Other</h3><p><b>Rare</b> (0.01% to 0.1%): Decreased drug effect/therapeutic response, increased drug effect/therapeutic response </p><p><b>Very rare</b> (less than 0.01%): Face edema<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Rare</b> (less than 0.1%): Delayed recovery from anesthesia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Rare</b> (0.01% to 0.1%): Tachycardia, hypotension</p><p><b>Very rare</b> (less than 0.01%): Circulatory collapse, shock, flushing<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very rare</b> (less than 0.01%): Angioneurotic edema, urticaria, rash, erythematous rash<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Vecuronium Bromide (vecuronium)." Hospira Inc, Lake Forest, IL. </p><h2>More about Norcuron (vecuronium)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: neuromuscular blocking agents</li>
<li>FDA Alerts (5)</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Anesthesia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>